ArticleThe British journal of cardiology2025
Different cardiac phenotypes of sickle cell disease revealed using cardiac magnetic resonance imaging.
Article in The British journal of cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sickle cell disease (SCD) is an inherited haematologic disorder with cardiac-related complications. Cardiac magnetic resonance (CMR) imaging allows us to assess the cardiac morphology and function of this population. Our aim was to better characterise phenotypic variations among SCD patients utilising CMR data. This retrospective study included 72 patients with SCD who underwent CMR between May 2013 and July 2023. We recorded baseline characteristics, medical history, and indication and setting of CMR. CMR parameters relating to morphology and function were collected. Patients were placed into the following groups based on cardiac parameters on CMR: high output, pulmonary hypertension (PH; defined by mean pulmonary artery pressure >20 mmHg on right heart catheterisation or elevated tricuspid regurgitation velocity >3.4 m/s on echocardiogram), left ventricular (LV) dysfunction, or normal size and function. Between- and within-group comparisons were performed. Demographic data were similar among groups. The PH group was more likely to have a history of smoking, chronic hypoxia, lower baseline haemoglobin, and need for blood transfusion (p<0.05 for all). There were significant between-group differences in CMR structural and function parameters. In conclusion, sickle cell patients present with different cardiac phenotypes. Patients with PH are associated with significantly higher morbidities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.